| Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention JY Xie, M De Felice, CM Kopruszinski, N Eyde, J LaVigne, B Remeniuk, ... Cephalalgia 37 (8), 780-794, 2017 | 95 | 2017 |
| Focus: Drug Development: Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain KM Olson, W Lei, A Keresztes, J LaVigne, JM Streicher The Yale journal of biology and medicine 90 (1), 97, 2017 | 47 | 2017 |
| The mixed-action delta/mu opioid agonist MMP-2200 does not produce conditioned place preference but does maintain drug self-administration in rats, and induces in vitro markers … GW Stevenson, A Luginbuhl, C Dunbar, J LaVigne, J Dutra, P Atherton, ... Pharmacology Biochemistry and Behavior 132, 49-55, 2015 | 37 | 2015 |
| Structure–Activity Relationships of [des-Arg7]Dynorphin A Analogues at the κ Opioid Receptor CN Ramos-Colon, YS Lee, M Remesic, SM Hall, J LaVigne, P Davis, ... Journal of medicinal chemistry 59 (22), 10291-10298, 2016 | 17 | 2016 |
| In Defense of the “Entourage Effect”: Terpenes Found in Cannabis sativa Activate the Cannabinoid Receptor 1 In Vivo J LaVigne, R Hecksel, JM Streicher The FASEB Journal 34 (S1), 1-1, 2020 | 13 | 2020 |
| The endomorphin-1/2 and dynorphin-B peptides display biased agonism at the mu opioid receptor J LaVigne, A Keresztes, D Chiem, JM Streicher Pharmacological Reports, 1-7, 2020 | 12 | 2020 |
| In Defense of the “Entourage Effect”: Terpenes Found in Cannabis sativa Activate the Cannabinoid Receptor 1 In Vitro R Hecksel, J LaVigne, JM Streicher The FASEB Journal 34 (S1), 1-1, 2020 | 3 | 2020 |
| (285) Phosphatidylethanolamine-binding protein regulates Mu opioid receptor induced βarrestin2 recruitment and downstream signaling K Edwards, J Bogusz, J LaVigne, K Pangilinan, J Streicher The Journal of Pain 17 (4), S47, 2016 | 1 | 2016 |
| EXPLORING OPIOID AND CANNABIS PHARMACOLOGY: BIASED SIGNALING OF ENDOGENOUS OPIOID PEPTIDES AND CANNABIMIMETIC PROPERTIES OF CANNABIS SATIVA TERPENES J LaVigne UNIVERSITY OF ARIZONA, 2020 | | 2020 |
| Phosphatidylethanolamine-Binding Protein Promotes Opioid Anti-Nociception in the Brain and Spinal Cord by Reducing βarrestin2 Recruitment to the Mu Opioid Receptor CYI Kim, J LaVigne, K Edwards, JM Streicher The FASEB Journal 32 (1_supplement), 689.3-689.3, 2018 | | 2018 |
| Phosphatidylethanolamine-binding protein regulates Mu opioid receptor induced beta arrestin2 recruitment and downstream signaling K Edwards, J Bogusz, J LaVigne, K Pangilinan, J Streicher JOURNAL OF PAIN 17 (4), S47-S47, 2016 | | 2016 |
| Phosphatidylethanolamine-Binding Protein Regulates Mu Opioid Receptor Induced βarrestin2 Recruitment and Downstream Signaling K Edwards, J LaVigne, K Pangilinan, J Streicher The FASEB Journal 29 (1_supplement), 929.9, 2015 | | 2015 |
| Identification of novel signaling regulators of the mu opioid receptor (1066.1) K Edwards, J LaVigne, E Moses‐Fynn, N Mullen, J Streicher The FASEB Journal 28, 1066.1, 2014 | | 2014 |
| The development of bifunctional ligands as novel therapeutics for chronic pain (1061.5) J LaVigne, K Edwards, E Bilsky, F Porreca, S Ananthan, E Roberts, ... The FASEB Journal 28 (1_supplement), 1061.5, 2014 | | 2014 |
| Unbiased Screens for Novel Signaling Regulators of the Mu Opioid Receptor: 223 J Streicher, E Moses-Fynn, J Lavigne Pain Medicine 15 (3), 2014 | | 2014 |
| Differential Potencies for Endogenous Dynorphins Indicate Functional Selectivity at the Delta Opioid Receptor KM Olson, J Lavigne, J Streicher, F Porreca, VJ Hruby | | |
